3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 2.160
-0.080 (-3.57%)
Jul 31, 2026, 2:03 PM HKT
3D Medicines Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 170.24 | 444.32 | 666.47 | 696.74 | 774.31 |
Short-Term Investments | 168.29 | 227.15 | 120.78 | 136.68 | - |
Trading Asset Securities | 99.38 | 169.52 | 209.33 | 108.6 | 50.18 |
Cash & Short-Term Investments | 437.91 | 840.98 | 996.58 | 942.03 | 824.48 |
Cash Growth | -47.93% | -15.61% | 5.79% | 14.26% | 99.02% |
Accounts Receivable | 20.71 | 47.86 | 5.46 | 78.04 | 65 |
Other Receivables | 77.94 | 75.54 | 79.54 | 76.63 | 7.29 |
Receivables | 102.44 | 127.09 | 85 | 155.91 | 72.29 |
Inventory | 3.51 | 4.06 | 4.61 | 1.2 | 0.01 |
Restricted Cash | - | - | - | - | 0.07 |
Other Current Assets | 13.37 | 15.62 | 8.97 | 43.93 | 22.37 |
Total Current Assets | 557.23 | 987.75 | 1,095 | 1,143 | 919.23 |
Property, Plant & Equipment | 137.6 | 147.73 | 193.25 | 177.84 | 118.54 |
Long-Term Investments | 87.08 | 23.34 | 70.59 | - | - |
Other Intangible Assets | 0.52 | 0.63 | 0.73 | 0.83 | 0.93 |
Other Long-Term Assets | 153.81 | 56.82 | 11.89 | 6.02 | 17.18 |
Total Assets | 936.24 | 1,216 | 1,429 | 1,332 | 1,060 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 89.18 | 51.13 | 71.9 | 15.88 | 3.74 |
Accrued Expenses | 66.35 | 166.04 | 124.35 | 183.83 | 111.18 |
Short-Term Debt | 120 | 195.59 | 174.37 | 103.99 | - |
Current Portion of Long-Term Debt | 16.5 | 9 | 27 | - | 3,094 |
Current Portion of Leases | 9.83 | 8.27 | 23.23 | 11.31 | 12.75 |
Current Income Taxes Payable | - | 0.06 | 1.91 | - | 1.43 |
Current Unearned Revenue | - | - | 24.54 | - | - |
Other Current Liabilities | 83.05 | 57.69 | 53.08 | 61.24 | 24.98 |
Total Current Liabilities | 384.92 | 487.79 | 500.37 | 376.25 | 3,248 |
Long-Term Debt | - | 16.5 | 29.24 | 27 | 38.82 |
Long-Term Leases | 6.45 | 8.25 | 28.58 | 33.4 | 45.99 |
Total Liabilities | 391.37 | 512.54 | 558.2 | 436.65 | 3,333 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.23 | 0.23 | 0.23 | 0.22 | 0.06 |
Additional Paid-In Capital | 4,798 | 4,785 | 4,785 | 4,228 | 134.66 |
Retained Earnings | -4,521 | -4,343 | -4,161 | -3,636 | -2,612 |
Treasury Stock | -0.01 | -0.17 | -0.01 | -0.03 | -0.03 |
Comprehensive Income & Other | 319.23 | 343.22 | 311.97 | 350.98 | 239.02 |
Total Common Equity | 596.73 | 785.06 | 936.74 | 943 | -2,238 |
Minority Interest | -51.85 | -81.35 | -66.05 | -47.59 | -34.55 |
Shareholders' Equity | 544.87 | 703.71 | 870.69 | 895.41 | -2,273 |
Total Liabilities & Equity | 936.24 | 1,216 | 1,429 | 1,332 | 1,060 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 152.78 | 237.62 | 282.43 | 175.7 | 3,192 |
Net Cash (Debt) | 285.13 | 603.36 | 714.15 | 766.33 | -2,367 |
Net Cash Growth | -52.74% | -15.51% | -6.81% | - | - |
Net Cash Per Share | 1.16 | 2.46 | 3.13 | 16.85 | -60.61 |
Filing Date Shares Outstanding | 245.92 | 244.97 | 245.07 | 224.2 | 36.45 |
Total Common Shares Outstanding | 245.92 | 244.97 | 245.07 | 224.2 | 36.45 |
Working Capital | 172.31 | 499.96 | 594.78 | 766.81 | -2,329 |
Book Value Per Share | 2.43 | 3.20 | 3.82 | 4.21 | -61.40 |
Tangible Book Value | 596.2 | 784.44 | 936.01 | 942.17 | -2,239 |
Tangible Book Value Per Share | 2.42 | 3.20 | 3.82 | 4.20 | -61.43 |
Machinery | 9.6 | 9.58 | 8.28 | 8.06 | 7.06 |
Construction In Progress | 112.02 | 112.02 | 112.02 | 99.87 | 28.16 |
Leasehold Improvements | 31.16 | 31.16 | 35.09 | 33.16 | 23.43 |